Circumvent Pharmaceuticals Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
11
Circumvent Pharmaceuticals General Information
Description
Developer of novel therapeutics designed to create precision medicines for neurodegenerative diseases. The company offers drug programs that are being made for Batten disease, a group of rare neurodegenerative diseases and other variants with the potential to impact both rare and common conditions and shares insights into brain-cell dysfunction, including synaptic function and palmitoylation, helping patients in curing and overcoming rare neurodegenerative diseases.
Contact Information
Corporate Office
- 4640 SouthWest Macadam Avenue
- Suite 200
- Portland, OR 97239
- United States
Corporate Office
- 4640 SouthWest Macadam Avenue
- Suite 200
- Portland, OR 97239
- United States
Circumvent Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 7. Equity Crowdfunding | 31-Dec-2021 | Completed | Generating Revenue | |||
| 6. Grant | 02-Nov-2021 | Completed | Generating Revenue | |||
| 5. Grant | 20-Sep-2021 | Completed | Generating Revenue | |||
| 4. Seed Round | 01-Nov-2020 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 19-Mar-2019 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2017 | $199K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Circumvent Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Circumvent Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Circumvent Pharmaceuticals Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CONNECT (San Diego) | Accelerator/Incubator | |||
| Age 1 | Venture Capital | Minority | ||
| DAYLI Partners | Venture Capital | Minority | ||
| Heritage Provider Network | Corporation | Minority | ||
| National Institutes of Neurological Disorders and Stroke | Government | Minority |
Circumvent Pharmaceuticals FAQs
-
When was Circumvent Pharmaceuticals founded?
Circumvent Pharmaceuticals was founded in 2017.
-
Where is Circumvent Pharmaceuticals headquartered?
Circumvent Pharmaceuticals is headquartered in Portland, OR.
-
What is the size of Circumvent Pharmaceuticals?
Circumvent Pharmaceuticals has 9 total employees.
-
What industry is Circumvent Pharmaceuticals in?
Circumvent Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Circumvent Pharmaceuticals a private or public company?
Circumvent Pharmaceuticals is a Private company.
-
What is Circumvent Pharmaceuticals’s current revenue?
The current revenue for Circumvent Pharmaceuticals is .
-
How much funding has Circumvent Pharmaceuticals raised over time?
Circumvent Pharmaceuticals has raised $4.25M.
-
Who are Circumvent Pharmaceuticals’s investors?
CONNECT (San Diego), Age 1, DAYLI Partners, Heritage Provider Network, and National Institutes of Neurological Disorders and Stroke are 5 of 11 investors who have invested in Circumvent Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
